Related links
Chapter 7 Recall Procedures
OE/DCP reviews and This recall will be reported in an upcoming issue of the weekly FDA Enforcement. Report. (Weekly status reports may also be required for
Learn more
Center for Drug Evaluation and Research Contents
May 25, 1999 it had submitted to FDA all mandatory postmarketing reports and other information concerning its approved drug products. FDA expected the.
Learn more
7345.848 - Inspection of Biological Drug Products,
CBER is responsible for ensuring biological drug products are safe and effective, and are in compliance with FDA and other applicable laws and regulations.
Learn more